$NOC

Northrop Grumman Corp (NOC) (Q3 2026) Earnings Call Highlights:

Northrop Grumman (NOC) reported Q3 2026 revenue of $11.1B (+7% YoY) with record backlog of $110B (+20% YoY). EPS grew 3% to $7.89. Adjusted free cash flow rose 40% to $1.8B. Guidance raised for full-year EPS and segment operating income. 2027 outlook projects 5-7% sales growth with margin expansion. B-21 program and international sales are key growth drivers. Microelectronics business under strategic review.

Original reporting
Published Oct 21, 2026, 4:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 4:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NOC
Bullish
high confidence
Mentioned
$NOC
Relevance
8/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$NOCBullishHigh
01

Why it matters

The earnings beat and guidance lift provide a clear catalyst for short‑term price appreciation.

02

Market read

Strong earnings and guidance raise expectations for the defense sector, likely prompting buying interest.

03

What to watch

Microelectronics foundry review could lead to a spin‑off, affecting long‑term valuation.

Relevance 8/10Novelty 8/10Timing: immediate release today

Background

Northrop Grumman posted Q3 2026 results, reaffirmed full‑year sales guidance and raised EPS outlook.

Company-level read

Ticker impact

$NOCBullishHigh confidence
Context

Q3 2026 earnings released with revenue up 7% YoY, EPS $7.89 and raised full-year EPS guidance by $0.70.

Expected impact

likely upward pressure as investors price in stronger revenue and EPS guidance.

Evidence & confidence

Record backlog, higher margins and a $0.70 EPS raise indicate improved profitability and demand, supporting a bullish move.

Market effects

Defense and aerospace sector may see broader rally on strong demand signals.

U.S. defense stocks could benefit from heightened investor interest.

Potential spillover to global defense contractors as backlog growth signals industry strength.

Counterpoint

Higher 2027 guidance range introduces uncertainty; increased CapEx may pressure cash flow.

Key entities

  • Kathy Warden

    CEO who discussed growth drivers and strategic reviews.

  • John Greene

    CFO who detailed cash flow and capex expectations.

Related articles

$NOCMed

Plans firm up for local solid rocket motor production

Australia plans to locally produce solid rocket motors (SRMs) with Northrop Grumman, backed by $126.9 million in initial funding. The SRMs will be used in Lockheed Martin's Guided Multiple Launch Rocket System (GMLRS). Northrop Grumman aims to begin industry engagements for local suppliers, with a 2030 deadline for production. A test flight of an Australian-made SRM was successful in August, developed with Thales.

$NOCHighAI 8/10

Key facts: Northrop Grumman (NOC) Q3; B-21 rates up, $2.5B; 50 sats/6mo

Northrop Grumman (NOC) reported Q3 revenue of $11.12B (+7% YoY), net income of $1.124B, and EPS of $7.89. Bookings were $16.4B with a backlog of ~$110B and a book-to-bill ratio of 1.5. The company raised its 2026 adjusted EPS outlook, completed the IMS divestiture, and plans to increase B-21 production rates with a $2.5B investment. It also aims to deploy 50 of 150 Space Systems satellites within six months.

$NOCMedAI 8/10

Northrop Grumman Corp (NOC) (Q3 2026) Earnings Call Highlights: Record $110 Billion Backlog

Northrop Grumman (NOC) reported a record $110 billion backlog. CEO Kathy Warden and CFO John Greene discussed 2027 growth outlook (5-7%), driven by programs like B-21, Sentinel, and international sales. They mentioned potential strategic moves for the microelectronics business. Free cash flow is expected to rise to $3.3B-$3.7B in 2027, supported by sales growth and margin expansion. All segments are projected to grow, with Defense Systems nearing 10% growth.